Misplaced Pages

Efloxate: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 18:33, 2 September 2011 editBogBot (talk \| contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot ← Previous edit		Revision as of 18:43, 2 September 2011 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[WikipedNext edit →
Line 1:		Line 1:
	{{Drugbox		{{Drugbox
			\| Watchedfields = changed
	\| verifiedrevid = ~~443323451~~		\| verifiedrevid = 444355205
	\| IUPAC_name = ethyl 2-acetate		\| IUPAC_name = ethyl 2-acetate
	\| image = Efloxate.png		\| image = Efloxate.png

Revision as of 18:43, 2 September 2011

Pharmaceutical compound

Efloxate
Clinical data

ATC code	C01DX13 (WHO)
Identifiers
IUPAC name ethyl 2-acetate
PubChem CID	8395
UNII	CZU6V3902K
CompTox Dashboard (EPA)	DTXSID3048736
ECHA InfoCard	100.003.929
Chemical and physical data
Formula	C₁₉H₁₆O₅
Molar mass	324.33 g/mol g·mol
(verify)

Efloxate is a vasodilator.

v t e Vasodilators used in cardiac diseases (C01D)
Nitrovasodilators	Nitroglycerin # Isosorbide dinitrate # Isosorbide mononitrate Itramin tosilate Linsidomine Molsidomine Nicorandil Pentaerythritol tetranitrate Propatylnitrate Tenitramine Trolnitrate
Quinolone vasodilators	Flosequinan
Others	Benziodarone Carbocromen Cinepazet Cloridarol Dilazep Efloxate Etafenone Gapicomine Heptaminol Hexobendine Imolamine Levosimendan Nesiritide Nicorandil Oxyfedrine Pimobendan Prenylamine Serelaxin Trapidil Vericiguat
WHO-EM Withdrawn from market Clinical trials: Phase III Never to phase III

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

v
t
e